David Apelian

Insider Reports History

Location
New Haven, CT
Signature
/s/ David Apelian
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Apelian:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eiger BioPharmaceuticals, Inc. CEO, Director Stock Option (Right to Buy) 750,000 03 Jul 2023 Direct

Insider Reports Filed by David Apelian

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000114036123033483-apelian-david-2023-07-03 Eiger BioPharmaceuticals, Inc. 03 Jul 2023 1 $0 4 CEO, Director 06 Jul 2023, 17:37
/report/000156761923001760-apelian-david-2023-01-31 Eiger BioPharmaceuticals, Inc. 31 Jan 2023 1 $0 4 Interim CEO, Director 02 Feb 2023, 20:12
/report/000156761922016461-apelian-david-2022-08-16 Eiger BioPharmaceuticals, Inc. 16 Aug 2022 1 -$49,030 4 Director 18 Aug 2022, 17:36
/report/000114036122009254-apelian-david-2022-03-11 Eiger BioPharmaceuticals, Inc. 11 Mar 2022 2 $0 4 Director 11 Mar 2022, 20:06